Evidence map›Paper›PMID 19187009›Full record

ArticleAssay and drug development technologies2009

Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

Karen M Kleman-Leyer, Tony A Klink, Andrew L Kopp, Thane A Westermeyer, Mark D Koeff, Brad R Larson, Tracy J Worzella, Cori A Pinchard, Sebastianus A T van de Kar, Guido J R Zaman and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Assay and drug development technologies, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Development of a Sensitive Assay for SERCA Activity Using FRET Detection of ADP.Analytical methods : advancing methods and applications · 2014
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Karen M Kleman-LeyerBellBrook Labs, 5500 Nobel Drive Suite 250, Madison, WI 53711, USA. karen.kleman@bellbrooklabs.com
Tony A Klink
Andrew L Kopp
Thane A Westermeyer
Mark D Koeff
Brad R Larson
Tracy J Worzella
Cori A Pinchard
Sebastianus A T van de Kar
Guido J R Zaman
Jorrit J Hornberg
Robert G Lowery
Bellbrook Labs (United States) · USMolecular Sciences Institute · US

Funding

Generic Fluorescent HTS Assay for Kinases and ATPasesR44CA110535 · NCI · BELLBROOK LABS, LLC · PI LOWERY, ROBERT G · 2006 to 2007
$648k
Generic Fluorescent HTS Assay for Protein KinasesR43CA110535 · NCI · BELLBROOK LABS, LLC · PI LOWERY, ROBERT G · 2005 to 2005
$173k
REGULATION OF FAK AND CELL MIGRATION WITH NOVEL FRNK-ERF32GM019795 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MARTIN, KAREN H · 1999 to 2000
$39k
NCI NIH HHS 2R44 CA110535-02NCI NIH HHS 5R44 CA110535-03NCI NIH HHS CA110535-01A1NIGMS NIH HHS F32 GM019795
6 · The paper itself

Abstract

ATP depletion and ADP formation are generic detection methods used for the identification of kinase and other ATP-utilizing enzyme inhibitors in high-throughput screening campaigns. However, the most widely used nucleotide detection approaches require high ATP consumption rates or involve the use of coupling enzymes, which can complicate the selection of lead compounds. As an alternative, we have developed the Transcreener (BellBrook Labs, Madison, WI) platform, which relies on the direct immunodetection of nucleotides. Here we describe the development of antibodies with >100-fold selectivity for ADP versus ATP, which enable robust detection of initial velocity rates (Z' > 0.7 at 10% substrate consumption) at ATP concentrations ranging from 0.1 microM to 1,000 microM in a competitive fluorescence polarization (FP) immunoassay. Competitive binding experiments indicate similar affinities for other nucleotide diphosphates, including 2' -deoxy ADP, GDP, and UDP. The antibody-tracer complex and the red-shifted, ratiometric FP signal are stable for at least 24 h at room temperature, providing suitable conditions for high-throughput screening. A method for calculating a kinase ATP Km with this FP immunoassay is also presented. The Transcreener ADP assay provides a simple, generic assay platform for inhibitor screening and selectivity profiling that can be used for any ADP-generating enzyme.

Indexed as

Adenosine DiphosphateAdenosine TriphosphateBuffersChromatography, High Pressure LiquidFluorescence Polarization ImmunoassayIndicators and ReagentsKineticsPeptide LibraryProtein KinasesReference StandardsAdenosine DiphosphateAdenosine TriphosphateBuffersIndicators and ReagentsPeptide LibraryProtein Kinases

Identifiers

PMID19187009
PMCPMC2956686
OpenAlexW2146643640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.